Navigation Links
The Leukemia & Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense
Date:6/18/2009

id. "This request clearly has merit for inclusion in the fiscal 2010 legislation."

The Department of Defense already hosts research programs for breast and prostate cancers and, from 2001-2007, hosted a chronic myelogenous leukemia (CML) research program funded at $30 million over the six year period.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (R) (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.

    Contact: Patrick Dyer
    patrick.dyer@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Taking Aim at Relapse of Leukemia in Kids
2. Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)
3. Study IDs benefit of donor SCT for adults with acute myeloid leukemia
4. Donor Stem-Cell Transplant Best For Acute Myeloid Leukemia
5. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
6. 5 Spanish centers join a study for a new leukemia and lymphoma treatment technique
7. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
8. Cole Foundation injects $2.5 million to bolster leukemia research
9. Leukemia Risk From MS Drug May Be Up
10. Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought
11. Researchers find drug that inhibits acute leukemia cell growth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...y found one more than doubled chances, while both .... 23 (HealthDay News) -- Children whose mothers sm...have more than double the risk of having attention...ildren, new research shows. , And with exposure...g ADHD soared. Children whose mothers smoked durin...
(Date:11/23/2009)..., SANTACLARA,Calif.,Nov.23/PRNewswire-FirstCall/...agnostictechnologyprovider,announcedtodaythatCEO,D...sentatthe2ndAnnualLDMICROConferenceonThursday,Dece...s. ,, Companymanagementwillbeavailableforone-on...ember3rd.PleasecontactBrettAimeeMaasat(646)536-733...
(Date:11/23/2009)... Recognized as Best New Techn...nce Software , Radnor, PA...rsquo;s fastest-growing Business Intelligence (BI)...ognized with the Healthcare IT Innovation™ A...for its flagship product, QlikView. The award was ...
(Date:11/23/2009)..., NORTHANDOVER,Mass.,Nov.23/PRNewswire/--Thistim...sandanxiety.Oftenthesefeelings,bothpositiveandnega...let,sfaceit,therearelotsofopportunitiestodosoallse...ieceofmom,sapplepie,buthowmanyofusstopthere?"Thatp...espentholidayseasonafterholidayseasontellingoursel...
(Date:11/23/2009)... The Institute of Women,s Hea...tial HIV Testing services at its affiliated campus... visit this webpage: FREE HIV TESTING SITE or ca... , (Vocus) November 23, 2...Immunodeficiency Virus (HIV) epidemic and yet, wit...
Breaking Medicine News(10 mins):Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 4Health News:Tis' the Season to Eat and Eat More! 2Health News:,The Institute of Women's Health of North America Increases its Outreach by Offering Free and Confidential HIV Testing in Florida, 2Health News:,The Institute of Women's Health of North America Increases its Outreach by Offering Free and Confidential HIV Testing in Florida, 3Health News:,The Institute of Women's Health of North America Increases its Outreach by Offering Free and Confidential HIV Testing in Florida, 4
...nges Modern Psychology and Explodes Myths of ,Why ...NA BEACH, Fla., Oct. 29 Some children have a,gene...fficult to raise than,others. The notion of ,there.... For years, classical and modern,psychology sugge...
...trics says heart problems in kids have been undere...ws) -- The emergency defibrillators now commonly f... saved thousands of adult cardiac arrest victims c... physicians as well -- that the devices can safely...
... that using a special type of drug called a pharma... beta6-TGF-beta pathway prevents a serious side ef... pulmonary fibrosis (scarring of the lungs), ther...American Society for Therapeutic Radiology and Onc...
..., Childrens Hospital of Pittsburgh of UPMC and the...joined forces to launch a new institute designed t...search. , The potential of this initiative has b...n Foundation Institute for Pediatric Research, whi...
...cal and emerging threats to global health and s...ese diseases, NEW YORK, Oct. 29 The 20th century...evements in public health. However, the,increased ...to the global community. As part of his ongoing Sc...
...ainCare Holdings,Inc. (Amex: PRZ ), one of the na...nd surgical solutions and services, today announce...held this past Friday in Orlando,Florida, sharehol...ending December 31, 2007. Re-elected board member...
Other Medicine News:Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3Health News:Defibrillator Use Urged to Save Children's Lives 2Health News:Defibrillator Use Urged to Save Children's Lives 3Health News:Preventing lung scarring may extend lives of lung cancer patients 2Health News:Collaboration to create pediatric research institute 2Health News:Collaboration to create pediatric research institute 3Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 2Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 3Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 4Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 2Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 3
(Date:11/20/2009).... 20 The Department of ...o members of priority groups that did not have pre...linics are being held statewide on Nov. 20-22. Fri... on Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On...p.m. to 8 p.m. ,, Individuals in the recommend...
(Date:11/20/2009)... ,, Reportlinker.com announces ...its catalogue. ,, Global Markets for Breast Bi....com/p0164741/Global-Markets-for-Breast-Biopsy-Dev...m=pr&utm_campaign=prnewswire ,, The globa...pring loaded core needle market and vacuum assiste...
(Date:11/20/2009)...RNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: ...and Chief Executive Officer, and Greg Browne, Chie...al Piper Jaffray Health Care Conference in New Yor... The conference session and webcast will be audio ...r Jaffray will host a webcast of the presentation ...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments 6263 1KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments 6263 2KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments 6263 3KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments 6263 4KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments 6263 5KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments 6263 6New Understanding of How the Brain Detects Emotion 61340 1New Understanding of How the Brain Detects Emotion 61340 2Employer Medicare Provisions of House Health Care Reform Detailed in New CCH Briefing 61335 1Employer Medicare Provisions of House Health Care Reform Detailed in New CCH Briefing 61335 2Employer Medicare Provisions of House Health Care Reform Detailed in New CCH Briefing 61335 3Employer Medicare Provisions of House Health Care Reform Detailed in New CCH Briefing 61335 4Employer Medicare Provisions of House Health Care Reform Detailed in New CCH Briefing 61335 5
.... 5 Tolerx, Inc., a,biopharmaceutical company eng...rapies for the treatment of immune-mediated diseas..., has moved a modified version of TRX1,MTRX1011A, ...inical trial,that has begun enrolling patients. Th...rability of both single and multiple doses of MTRX...
...5 /PRNewswire/-- Cara Therapeutics, Inc. today,ann...its second-generation,peripherally acting kappa op...atment of acute and chronic pain. The drug candida...nfusion, and resulted in plasma levels of,CR845 ex...tivity. In,addition, CR845 infusion triggered a qu...
Other Medicine Technology:Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845 2
Blood Storage Refrigerator TBR-200-1-GD
Testosterone ELISA
Ultra-Sensitive Testosterone EIA
Steroid 21-Hydroxylase (21-OH) Autoantibody RIA
Medicine Products: